TD Cowen Maintains Buy on Danaher, Raises Price Target to $255

10/13/2026
Impact: 75
Healthcare

TD Cowen analyst Dan Brennan has maintained a Buy rating on Danaher (NYSE: DHR) and increased the price target from $236 to $255.

AI summary, not financial advice

Share: